The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Methotrexate 2.5 mg tablets

2.5 milligram(s) Tablet

Accord Healthcare Ireland Ltd.PA2315/062/001

Main Information

Trade NameMethotrexate 2.5 mg tablets
Active SubstancesMethotrexate
Strength2.5 milligram(s)
Dosage FormTablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/062/001

Group Information

ATC CodeL01BA Folic acid analogues
L01BA01 methotrexate

Status

Authorised/WithdrawnAuthorised
Licence Issued01/07/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListMethotrexate 2.5mg Tablets
Interchangeable List CodeIC0098-018-002
Interchangeable List DocumentPDF of Interchangeable List
« Back